GOECP/SEOR radiotherapy guidelines for thymic epithelial tumours.

Area of Science:

• Oncology
• Pathology
• Radiotherapy

Background:

• Thymic epithelial tumors (TETs) are rare, heterogeneous neoplasms with complex pathological diagnosis and limited evidence for management.
• Current clinical management of TETs is highly variable due to scant evidence, often relying on non-randomized studies.
• Advances in radiotherapy and systemic therapies for TETs have been underrepresented in clinical practice.

Purpose of the Study:

• To review recent developments in the diagnosis and classification of thymic epithelial tumors.
• To present a consensus-based therapeutic strategy for each disease stage of TETs, integrating the best available evidence.
• To promote standardization of clinical practice in TET management and establish a foundation for future research.

Main Methods:

• Development of clinical guidelines by the GOECP/SEOR.
• Review of recent advancements in TET diagnosis and classification.
• Formulation of a consensus-based therapeutic strategy considering current evidence.

Main Results:

• Recent developments in TET diagnosis and classification are reviewed.
• A consensus-based therapeutic strategy for all TET disease stages is presented.
• The guidelines emphasize the role of radiotherapy, including recent technological advances, in TET management.

Conclusions:

• Standardization of clinical practice for thymic epithelial tumors is crucial.
• These guidelines provide a framework for managing TETs based on current evidence and expert consensus.
• Further studies are needed to address unresolved questions in the optimal management of TETs.